---
schema_version: "secwatch.filing_event.v1"
accession: "0001077183-26-000031"
form_type: "8-K"
ticker: "NEO"
cik: "0001077183"
company_name: "NEOGENOMICS INC"
filed_at: "2026-06-17T10:05:23+00:00"
generated_at: "2026-06-17T10:10:08.291905+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# NeoGenomics prices $275M convertible notes due 2032; to repurchase $276M of existing notes

## Summary
- $275M principal of 0.75% convertible notes due 2032; initial purchasers have option for additional $41.25M.
- Initial conversion price ~$14.16/share, a 35% premium to $10.49 closing price on June 16, 2026.
- Net proceeds ~$266.15M; ~$25M used for capped call transactions (cap price $20.98/share).
- Concurrently repurchasing $276M of existing 0.25% convertible notes due 2028 for ~$263.19M.
- Also plans to repurchase up to $25M of common stock from certain note purchasers; offering expected to close June 22, 2026.

## SEC filing metadata
- accession: 0001077183-26-000031
- form_type: 8-K
- ticker: NEO
- cik: 0001077183
- company_name: NEOGENOMICS INC
- filed_at: 2026-06-17T10:05:23+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1077183/000107718326000031/0001077183-26-000031-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1077183/000107718326000031/neo-20260617.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001077183-26-000031
- JSON: https://secwatch.observer/filing/0001077183-26-000031.json
- Plain text: https://secwatch.observer/filing/0001077183-26-000031.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.